A detailed history of Farther Finance Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 1,247 shares of VCEL stock, worth $71,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,247
Previous 842 48.1%
Holding current value
$71,490
Previous $37.9 Million 38.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$42.25 - $53.56 $17,111 - $21,691
405 Added 48.1%
1,247 $52.7 Million
Q2 2024

Jul 31, 2024

BUY
$41.71 - $52.9 $35,119 - $44,541
842 New
842 $37.9 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.